Anavex Life Sciences
AVXL
#9983
Rank
ยฃ57.41 M
Marketcap
ยฃ0.62
Share price
-12.42%
Change (1 day)
-77.23%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2026 (TTM): -ยฃ0.11

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -ยฃ0.11. In 2025 the company made an earnings per share (EPS) of -ยฃ0.35.

EPS history for Anavex Life Sciences from 2025 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.11-68.06%
2025-ยฃ0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ1.96-1,826.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ1.14-1,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ5.72 4,933.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ1.02 800.00%๐Ÿ‡บ๐Ÿ‡ธ USA